{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T18:07:04Z","timestamp":1791223624297,"version":"4.1.0"},"reference-count":110,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1681\/asn.2014121192","type":"journal-article","created":{"date-parts":[[2015,5,7]],"date-time":"2015-05-07T22:40:51Z","timestamp":1431038451000},"page":"2081-2095","source":"Crossref","is-referenced-by-count":40,"title":["The Future of Polycystic Kidney Disease Research\u2014As Seen By the 12 Kaplan Awardees"],"prefix":"10.1681","volume":"26","author":[{"given":"Corinne","family":"Antignac","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Calvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory G.","family":"Germino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jared J.","family":"Grantham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M.","family":"Guay-Woodford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter C.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedhelm","family":"Hildebrandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien J.M.","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Somlo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vicente E.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerd","family":"Walz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan S.L.","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20230208","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1681\/ASN.2012070650","article-title":"Type of PKD1 mutation influences renal outcome in ADPKD.","volume":"24","author":"Cornec-Le Gall","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R2-7-20230208","doi-asserted-by":"crossref","first-page":"38818","DOI":"10.1074\/jbc.M110.145284","article-title":"MAP\/ERK kinase kinase 1 (MEKK1) mediates transcriptional repression by interacting with polycystic kidney disease-1 (PKD1) promoter-bound p53 tumor suppressor protein.","volume":"285","author":"Islam","year":"2010","journal-title":"J Biol Chem"},{"key":"R3-7-20230208","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/ki.2008.686","article-title":"Incompletely penetrant PKD1 alleles suggest a role for gene dosage in cyst initiation in polycystic kidney disease.","volume":"75","author":"Rossetti","year":"2009","journal-title":"Kidney Int"},{"key":"R4-7-20230208","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1681\/ASN.2009101070","article-title":"Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.","volume":"21","author":"Vujic","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R5-7-20230208","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1681\/ASN.2010101080","article-title":"Mutations in multiple PKD genes may explain early and severe polycystic kidney disease.","volume":"22","author":"Bergmann","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"R6-7-20230208","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1136\/jmg.30.7.583","article-title":"Childhood onset autosomal dominant polycystic kidney disease in sibs: clinical picture and recurrence risk. German Working Group on Paediatric Nephrology (Arbeitsgemeinschaft f\u00fcr P\u00e4diatrische Nephrologie.","volume":"30","author":"Zerres","year":"1993","journal-title":"J Med Genet"},{"key":"R7-7-20230208","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI64313","article-title":"Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.","volume":"122","author":"Hopp","year":"2012","journal-title":"J Clin Invest"},{"key":"R8-7-20230208","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1681\/ASN.2013121312","article-title":"Tolvaptan plus pasireotide shows enhanced efficacy in a PKD1 model","volume":"26","author":"Hopp","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R9-7-20230208","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1681\/ASN.2013040417","article-title":"The mutation, a key determinant of phenotype in ADPKD.","volume":"24","author":"Harris","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"R10-7-20230208","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1111\/j.1600-6143.2007.02030.x","article-title":"Mosaicism in autosomal dominant polycystic kidney disease revealed by genetic testing to enable living related renal transplantation.","volume":"8","author":"Connor","year":"2008","journal-title":"Am J Transplant"},{"key":"R11-7-20230208","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1038\/ki.2008.485","article-title":"Characterization of large rearrangements in autosomal dominant polycystic kidney disease and the PKD1\/TSC2 contiguous gene syndrome.","volume":"74","author":"Consugar","year":"2008","journal-title":"Kidney Int"},{"key":"R12-7-20230208","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2369-14-59","article-title":"Autosomal dominant polycystic kidney disease in a family with mosaicism and hypomorphic allele.","volume":"14","author":"Reiterov\u00e1","year":"2013","journal-title":"BMC Nephrol"},{"key":"R13-7-20230208","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1002\/path.2765","article-title":"Progressive renal distortion by multiple cysts in transgenic mice expressing artificial microRNAs against Pkd1.","volume":"222","author":"Wang","year":"2010","journal-title":"J Pathol"},{"key":"R14-7-20230208","doi-asserted-by":"crossref","first-page":"3542","DOI":"10.1172\/JCI58183","article-title":"Reduction of ER stress via a chemical chaperone prevents disease phenotypes in a mouse model of primary open angle glaucoma.","volume":"121","author":"Zode","year":"2011","journal-title":"J Clin Invest"},{"key":"R15-7-20230208","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1038\/nature05756","article-title":"PTC124 targets genetic disorders caused by nonsense mutations.","volume":"447","author":"Welch","year":"2007","journal-title":"Nature"},{"key":"R16-7-20230208","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1097\/MCP.0b013e328365ab5f","article-title":"Modifying disease in cystic fibrosis: current and future therapies on the horizon.","volume":"19","author":"Ong","year":"2013","journal-title":"Curr Opin Pulm Med"},{"key":"R17-7-20230208","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0092-8674(00)81793-6","article-title":"The molecular basis of focal cyst formation in human autosomal dominant polycystic kidney disease type I.","volume":"87","author":"Qian","year":"1996","journal-title":"Cell"},{"key":"R18-7-20230208","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S1097-2765(00)80135-5","article-title":"Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease.","volume":"2","author":"Watnick","year":"1998","journal-title":"Mol Cell"},{"key":"R19-7-20230208","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1681\/ASN.V1071524","article-title":"Somatic PKD2 mutations in individual kidney and liver cysts support a \u201ctwo-hit\u201d model of cystogenesis in type 2 autosomal dominant polycystic kidney disease.","volume":"10","author":"Pei","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"R20-7-20230208","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0092-8674(00)81570-6","article-title":"Somatic inactivation of Pkd2 results in polycystic kidney disease.","volume":"93","author":"Wu","year":"1998","journal-title":"Cell"},{"key":"R21-7-20230208","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1097\/01.ASN.0000144204.01352.86","article-title":"A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo.","volume":"15","author":"Piontek","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"R22-7-20230208","doi-asserted-by":"crossref","first-page":"18688","DOI":"10.1073\/pnas.0708217104","article-title":"Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure.","volume":"104","author":"Yu","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R23-7-20230208","doi-asserted-by":"crossref","first-page":"1490","DOI":"10.1038\/nm1675","article-title":"A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1.","volume":"13","author":"Piontek","year":"2007","journal-title":"Nat Med"},{"key":"R24-7-20230208","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1681\/ASN.2006030295","article-title":"Early embryonic renal tubules of wild-type and polycystic kidney disease kidneys respond to cAMP stimulation with cystic fibrosis transmembrane conductance regulator\/Na+,K+,2Cl\u2013 Co-transporter-dependent cystic dilation.","volume":"17","author":"Magenheimer","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"R25-7-20230208","doi-asserted-by":"crossref","first-page":"e1003053","DOI":"10.1371\/journal.pgen.1003053","article-title":"Network analysis of a Pkd1-mouse model of autosomal dominant polycystic kidney disease identifies HNF4\u03b1 as a disease modifier.","volume":"8","author":"Menezes","year":"2012","journal-title":"PLoS Genet"},{"key":"R26-7-20230208","doi-asserted-by":"crossref","first-page":"3069","DOI":"10.1093\/hmg\/ddh336","article-title":"Lowering of Pkd1 expression is sufficient to cause polycystic kidney disease.","volume":"13","author":"Lantinga-van Leeuwen","year":"2004","journal-title":"Hum Mol Genet"},{"key":"R27-7-20230208","doi-asserted-by":"crossref","first-page":"3188","DOI":"10.1093\/hmg\/ddm299","article-title":"Kidney-specific inactivation of the Pkd1 gene induces rapid cyst formation in developing kidneys and a slow onset of disease in adult mice.","volume":"16","author":"Lantinga-van Leeuwen","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R28-7-20230208","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.00550110","article-title":"Evidence of extraordinary growth in the progressive enlargement of renal cysts.","volume":"5","author":"Grantham","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"R29-7-20230208","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/hmg\/ddn045","article-title":"Acute kidney injury and aberrant planar cell polarity induce cyst formation in mice lacking renal cilia.","volume":"17","author":"Patel","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R30-7-20230208","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1093\/hmg\/ddp190","article-title":"Toxic tubular injury in kidneys from Pkd1-deletion mice accelerates cystogenesis accompanied by dysregulated planar cell polarity and canonical Wnt signaling pathways.","volume":"18","author":"Happ\u00e9","year":"2009","journal-title":"Hum Mol Genet"},{"key":"R32-7-20230208","first-page":"131","article-title":"Autocrine, endocrine and paracrine regulation of growth abnormalities in autosomal dominant polycystic kidney disease.","volume":"61","author":"Wilson","year":"1993","journal-title":"Eur J Cell Biol"},{"key":"R33-7-20230208","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1681\/ASN.2004121083","article-title":"Kinesin family member 12 is a candidate polycystic kidney disease modifier in the cpk mouse.","volume":"16","author":"Mrug","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R34-7-20230208","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1007\/s00109-014-1185-7","article-title":"Intragenic motifs regulate the transcriptional complexity of Pkhd1\/PKHD1.","volume":"92(10)","author":"Boddu","year":"2014","journal-title":"J Mol Med (Berl"},{"key":"R35-7-20230208","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1681\/ASN.2007010125","article-title":"Genotype-phenotype correlations in autosomal dominant and autosomal recessive polycystic kidney disease.","volume":"18","author":"Rossetti","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"R36-7-20230208","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1172\/JCI0214099","article-title":"Cystin, a novel cilia-associated protein, is disrupted in the cpk mouse model of polycystic kidney disease.","volume":"109","author":"Hou","year":"2002","journal-title":"J Clin Invest"},{"key":"R37-7-20230208","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1093\/hmg\/ddm141","article-title":"Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway.","volume":"16","author":"Garcia-Gonzalez","year":"2007","journal-title":"Hum Mol Genet"},{"key":"R38-7-20230208","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/s00467-014-2917-1","article-title":"Clinical and genetic characterization of a founder PKHD1 mutation in Afrikaners with ARPKD.","volume":"30","author":"Lambie","year":"2015","journal-title":"Pediatr Nephrol"},{"key":"R39-7-20230208","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/gbb.12029","article-title":"High-precision genetic mapping of behavioral traits in the diversity outbred mouse population.","volume":"12","author":"Logan","year":"2013","journal-title":"Genes Brain Behav"},{"key":"R40-7-20230208","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1172\/JCI72272","article-title":"Genetic mechanisms and signaling pathways in autosomal dominant polycystic kidney disease.","volume":"124","author":"Harris","year":"2014","journal-title":"J Clin Invest"},{"key":"R41-7-20230208","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1681\/ASN.2013040398","article-title":"Strategies targeting cAMP signaling in the treatment of polycystic kidney disease.","volume":"25","author":"Torres","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R42-7-20230208","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1681\/ASN.2013060604","article-title":"CKD and the risk of incident cancer.","volume":"25","author":"Lowrance","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R43-7-20230208","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1681\/ASN.V491661","article-title":"Renal cell carcinoma in autosomal dominant polycystic kidney disease.","volume":"4","author":"Keith","year":"1994","journal-title":"J Am Soc Nephrol"},{"key":"R44-7-20230208","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/j.urology.2009.02.078","article-title":"Prevalence of renal cell carcinoma in patients with autosomal dominant polycystic kidney disease and chronic renal failure.","volume":"74","author":"Hajj","year":"2009","journal-title":"Urology"},{"key":"R45-7-20230208","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000351049","article-title":"Autosomal dominant polycystic kidney disease: prevalence of renal neoplasias in surgical kidney specimens.","volume":"123","author":"Jilg","year":"2013","journal-title":"Nephron Clin Pract"},{"key":"R46-7-20230208","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1681\/ASN.2013101122","article-title":"Polycystic kidney disease and cancer after renal transplantation.","volume":"25","author":"Wetmore","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R47-7-20230208","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1007\/s00439-011-0950-8","article-title":"Germline PKHD1 mutations are protective against colorectal cancer.","volume":"129","author":"Ward","year":"2011","journal-title":"Hum Genet"},{"key":"R48-7-20230208","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/sj.ki.5002629","article-title":"Calcium channel inhibition accelerates polycystic kidney disease progression in the Cy\/+ rat.","volume":"73","author":"Nagao","year":"2008","journal-title":"Kidney Int"},{"key":"R49-7-20230208","doi-asserted-by":"crossref","first-page":"40419","DOI":"10.1074\/jbc.M405079200","article-title":"Calcium restriction allows cAMP activation of the B-Raf\/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype.","volume":"279","author":"Yamaguchi","year":"2004","journal-title":"J Biol Chem"},{"key":"R50-7-20230208","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/ncb2491","article-title":"MYC suppresses cancer metastasis by direct transcriptional silencing of \u03b1v and \u03b23 integrin subunits.","volume":"14","author":"Liu","year":"2012","journal-title":"Nat Cell Biol"},{"key":"R51-7-20230208","doi-asserted-by":"crossref","first-page":"242ra284","DOI":"10.1126\/scitranslmed.3008455","article-title":"COX-2 Inhibition Potentiates Antiangiogenic Cancer Therapy and Prevents Metastasis in Preclinical Models.","volume":"6","author":"Xu","year":"2014","journal-title":"Sci Transl Med"},{"key":"R52-7-20230208","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1053\/j.ackd.2010.01.002","article-title":"Molecular advances in autosomal dominant polycystic kidney disease.","volume":"17","author":"Gallagher","year":"2010","journal-title":"Adv Chronic Kidney Dis"},{"key":"R53-7-20230208","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1056\/NEJMra1010172","article-title":"Ciliopathies.","volume":"364","author":"Hildebrandt","year":"2011","journal-title":"N Engl J Med"},{"key":"R54-7-20230208","doi-asserted-by":"crossref","first-page":"R378","DOI":"10.1016\/S0960-9822(02)00877-1","article-title":"Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease.","volume":"12","author":"Pazour","year":"2002","journal-title":"Curr Biol"},{"key":"R55-7-20230208","doi-asserted-by":"crossref","first-page":"2508","DOI":"10.1097\/01.ASN.0000029587.47950.25","article-title":"The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia.","volume":"13","author":"Yoder","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"R56-7-20230208","doi-asserted-by":"crossref","first-page":"5286","DOI":"10.1073\/pnas.0836980100","article-title":"Kidney-specific inactivation of the KIF3A subunit of kinesin-II inhibits renal ciliogenesis and produces polycystic kidney disease.","volume":"100","author":"Lin","year":"2003","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R57-7-20230208","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/hmg\/ddn039","article-title":"Cyst formation and activation of the extracellular regulated kinase pathway after kidney specific inactivation of Pkd1.","volume":"17","author":"Shibazaki","year":"2008","journal-title":"Hum Mol Genet"},{"key":"R58-7-20230208","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/ng.2715","article-title":"Loss of cilia suppresses cyst growth in genetic models of autosomal dominant polycystic kidney disease.","volume":"45","author":"Ma","year":"2013","journal-title":"Nat Genet"},{"key":"R59-7-20230208","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1146\/annurev.physiol.70.113006.100621","article-title":"Polycystins and primary cilia: primers for cell cycle progression.","volume":"71","author":"Zhou","year":"2009","journal-title":"Annu Rev Physiol"},{"key":"R60-7-20230208","doi-asserted-by":"crossref","first-page":"11276","DOI":"10.1074\/jbc.M110483200","article-title":"Constitutive activation of G-proteins by polycystin-1 is antagonized by polycystin-2.","volume":"277","author":"Delmas","year":"2002","journal-title":"J Biol Chem"},{"key":"R61-7-20230208","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1038\/ng1076","article-title":"Polycystins 1 and 2 mediate mechanosensation in the primary cilium of kidney cells.","volume":"33","author":"Nauli","year":"2003","journal-title":"Nat Genet"},{"key":"R62-7-20230208","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00018-013-1483-1","article-title":"Cilioplasm is a cellular compartment for calcium signaling in response to mechanical and chemical stimuli.","volume":"71","author":"Jin","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"R63-7-20230208","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/nature12833","article-title":"Primary cilia are specialized calcium signalling organelles.","volume":"504","author":"Delling","year":"2013","journal-title":"Nature"},{"key":"R64-7-20230208","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.1128\/MCB.00072-07","article-title":"Fibrocystin\/polyductin, found in the same protein complex with polycystin-2, regulates calcium responses in kidney epithelia.","volume":"27","author":"Wang","year":"2007","journal-title":"Mol Cell Biol"},{"key":"R65-7-20230208","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1681\/ASN.2006090985","article-title":"Nek8 regulates the expression and localization of polycystin-1 and polycystin-2.","volume":"19","author":"Sohara","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R66-7-20230208","doi-asserted-by":"crossref","first-page":"5441","DOI":"10.1093\/hmg\/ddu267","article-title":"Bardet-Biedl syndrome proteins 1 and 3 regulate the ciliary trafficking of polycystic kidney disease 1 protein.","volume":"23","author":"Su","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R67-7-20230208","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1093\/hmg\/ddt672","article-title":"Polycystin-1 regulates actin cytoskeleton organization and directional cell migration through a novel PC1-Pacsin 2-N-Wasp complex.","volume":"23","author":"Yao","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R68-7-20230208","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/ng.400","article-title":"Wnt9b signaling regulates planar cell polarity and kidney tubule morphogenesis.","volume":"41","author":"Karner","year":"2009","journal-title":"Nat Genet"},{"key":"R69-7-20230208","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.cell.2012.06.028","article-title":"Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling.","volume":"150","author":"Chaki","year":"2012","journal-title":"Cell"},{"key":"R70-7-20230208","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1101\/gad.1627708","article-title":"Cep164 is a mediator protein required for the maintenance of genomic stability through modulation of MDC1, RPA, and CHK1.","volume":"22","author":"Sivasubramaniam","year":"2008","journal-title":"Genes Dev"},{"key":"R71-7-20230208","first-page":"54","article-title":"Systemic karyomegaly associated with chronic interstitial nephritis. A new disease entity?","volume":"12","author":"Mihatsch","year":"1979","journal-title":"Clin Nephrol"},{"key":"R72-7-20230208","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/ng.2347","article-title":"FAN1 mutations cause karyomegalic interstitial nephritis, linking chronic kidney failure to defective DNA damage repair.","volume":"44","author":"Zhou","year":"2012","journal-title":"Nat Genet"},{"key":"R73-7-20230208","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.4161\/cc.22375","article-title":"CDK inhibitors R-roscovitine and S-CR8 effectively block renal and hepatic cystogenesis in an orthologous model of ADPKD.","volume":"11","author":"Bukanov","year":"2012","journal-title":"Cell Cycle"},{"key":"R74-7-20230208","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00441-010-0983-7","article-title":"Primary cilia disappear in rat podocytes during glomerular development.","volume":"341","author":"Ichimura","year":"2010","journal-title":"Cell Tissue Res"},{"key":"R75-7-20230208","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1681\/ASN.2013101126","article-title":"A homozygous missense mutation in the ciliary gene TTC21B causes familial FSGS.","volume":"25","author":"Huynh Cong","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"R76-7-20230208","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/ng.756","article-title":"TTC21B contributes both causal and modifying alleles across the ciliopathy spectrum.","volume":"43","author":"Davis","year":"2011","journal-title":"Nat Genet"},{"key":"R77-7-20230208","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/nrneph.2011.151","article-title":"The podocyte cytoskeleton\u2014key to a functioning glomerulus in health and disease.","volume":"8","author":"Welsh","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"R78-7-20230208","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1681\/ASN.2013040421","article-title":"Phosphodiesterase 1A Modulates Cystogenesis in Zebrafish.","volume":"25","author":"Sussman","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"R79-7-20230208","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1038\/ki.2013.418","article-title":"Anoctamin 1 induces calcium-activated chloride secretion and proliferation of renal cyst-forming epithelial cells.","volume":"85","author":"Buchholz","year":"2014","journal-title":"Kidney Int"},{"key":"R80-7-20230208","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1093\/hmg\/ddu208","article-title":"An mTOR anti-sense oligonucleotide decreases polycystic kidney disease in mice with a targeted mutation in Pkd2.","volume":"23","author":"Ravichandran","year":"2014","journal-title":"Hum Mol Genet"},{"key":"R81-7-20230208","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1056\/NEJMoa0907419","article-title":"Sirolimus and kidney growth in autosomal dominant polycystic kidney disease.","volume":"363","author":"Serra","year":"2010","journal-title":"N Engl J Med"},{"key":"R82-7-20230208","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1681\/ASN.2009121302","article-title":"Sirolimus therapy to halt the progression of ADPKD.","volume":"21","author":"Perico","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R83-7-20230208","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1003491","article-title":"Everolimus in patients with autosomal dominant polycystic kidney disease.","volume":"363","author":"Walz","year":"2010","journal-title":"N Engl J Med"},{"key":"R84-7-20230208","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1172\/JCI64401","article-title":"Sirtuin 1 inhibition delays cyst formation in autosomal-dominant polycystic kidney disease.","volume":"123","author":"Zhou","year":"2013","journal-title":"J Clin Invest"},{"key":"R85-7-20230208","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/nm.3092","article-title":"Defective glucose metabolism in polycystic kidney disease identifies a new therapeutic strategy.","volume":"19","author":"Rowe","year":"2013","journal-title":"Nat Med"},{"key":"R86-7-20230208","doi-asserted-by":"crossref","first-page":"F1243","DOI":"10.1152\/ajprenal.00694.2013","article-title":"Effects of combined administration of rapamycin, tolvaptan, and AEZ-131 on the progression of polycystic disease in PCK rats.","volume":"306","author":"Sabbatini","year":"2014","journal-title":"Am J Physiol Renal Physiol"},{"key":"R87-7-20230208","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1755-8417-2-6","article-title":"Emerging evidence of a link between the polycystins and the mTOR pathways.","volume":"2","author":"Boletta","year":"2009","journal-title":"Pathogenetics"},{"key":"R88-7-20230208","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1016\/j.molmed.2011.06.003","article-title":"mTOR signaling in polycystic kidney disease.","volume":"17","author":"Ibraghimov-Beskrovnaya","year":"2011","journal-title":"Trends Mol Med"},{"key":"R89-7-20230208","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/ncb2117","article-title":"Primary cilia regulate mTORC1 activity and cell size through Lkb1.","volume":"12","author":"Boehlke","year":"2010","journal-title":"Nat Cell Biol"},{"key":"R90-7-20230208","doi-asserted-by":"crossref","first-page":"5466","DOI":"10.1073\/pnas.0509694103","article-title":"The mTOR pathway is regulated by polycystin-1, and its inhibition reverses renal cystogenesis in polycystic kidney disease.","volume":"103","author":"Shillingford","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R91-7-20230208","doi-asserted-by":"crossref","first-page":"e9239","DOI":"10.1371\/journal.pone.0009239","article-title":"Carboxy terminal tail of polycystin-1 regulates localization of TSC2 to repress mTOR.","volume":"5","author":"Dere","year":"2010","journal-title":"PLoS ONE"},{"key":"R92-7-20230208","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1128\/MCB.01259-08","article-title":"Polycystin-1 regulates extracellular signal-regulated kinase-dependent phosphorylation of tuberin to control cell size through mTOR and its downstream effectors S6K and 4EBP1.","volume":"29","author":"Distefano","year":"2009","journal-title":"Mol Cell Biol"},{"key":"R93-7-20230208","doi-asserted-by":"crossref","first-page":"3617","DOI":"10.1172\/JCI41531","article-title":"Failure to ubiquitinate c-Met leads to hyperactivation of mTOR signaling in a mouse model of autosomal dominant polycystic kidney disease.","volume":"120","author":"Qin","year":"2010","journal-title":"J Clin Invest"},{"key":"R94-7-20230208","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1681\/ASN.2004080660","article-title":"Rapamycin markedly slows disease progression in a rat model of polycystic kidney disease.","volume":"16","author":"Tao","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"R95-7-20230208","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1093\/ndt\/gfi181","article-title":"Inhibition of mTOR with sirolimus slows disease progression in Han:SPRD rats with autosomal dominant polycystic kidney disease (ADPKD).","volume":"21","author":"Wahl","year":"2006","journal-title":"Nephrol Dial Transplant"},{"key":"R96-7-20230208","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1681\/ASN.2009040421","article-title":"Rapamycin ameliorates PKD resulting from conditional inactivation of Pkd1.","volume":"21","author":"Shillingford","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"R97-7-20230208","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1038\/ki.2010.250","article-title":"Sirolimus attenuates disease progression in an orthologous mouse model of human autosomal dominant polycystic kidney disease.","volume":"78","author":"Zafar","year":"2010","journal-title":"Kidney Int"},{"key":"R98-7-20230208","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1681\/ASN.2012040367","article-title":"Folate-conjugated rapamycin slows progression of polycystic kidney disease.","volume":"23","author":"Shillingford","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R99-7-20230208","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1440-1797.2012.01639.x","article-title":"Rapamycin-mediated suppression of renal cyst expansion in del34 Pkd1-\/- mutant mouse embryos: an investigation of the feasibility of renal cyst prevention in the foetus.","volume":"17","author":"Stayner","year":"2012","journal-title":"Nephrology (Carlton"},{"key":"R100-7-20230208","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1681\/ASN.2011040340","article-title":"Dose-dependent effects of sirolimus on mTOR signaling and polycystic kidney disease.","volume":"23","author":"Novalic","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"R101-7-20230208","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1016\/j.transproceed.2012.06.073","article-title":"Sirolimus produced S-shaped effect on adult polycystic kidneys after 2-year treatment.","volume":"44","author":"Soliman","year":"2012","journal-title":"Transplant Proc"},{"key":"R102-7-20230208","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/ndt\/gfs519","article-title":"mTOR inhibition in autosomal-dominant polycystic kidney disease (ADPKD): the question remains open.","volume":"28","author":"Jardine","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"R103-7-20230208","doi-asserted-by":"crossref","first-page":"881","DOI":"10.2215\/CJN.02650313","article-title":"Low-dose rapamycin (sirolimus) effects in autosomal dominant polycystic kidney disease: an open-label randomized controlled pilot study.","volume":"9","author":"Braun","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"R104-7-20230208","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S0272-6386(12)80507-5","article-title":"Polycystic kidney disease: neoplasia in disguise.","volume":"15","author":"Grantham","year":"1990","journal-title":"Am J Kidney Dis"},{"key":"R105-7-20230208","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1038\/ki.1987.121","article-title":"Cyst formation and growth in autosomal dominant polycystic kidney disease.","volume":"31","author":"Grantham","year":"1987","journal-title":"Kidney Int"},{"key":"R106-7-20230208","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/nrneph.2011.109","article-title":"Why kidneys fail in autosomal dominant polycystic kidney disease.","volume":"7","author":"Grantham","year":"2011","journal-title":"Nat Rev Nephrol"},{"key":"R107-7-20230208","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1681\/ASN.2007080862","article-title":"Generation and evolution of atubular glomeruli in the progression of renal disorders.","volume":"19","author":"Chevalier","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"R108-7-20230208","doi-asserted-by":"crossref","first-page":"F110","DOI":"10.1152\/ajprenal.00022.2011","article-title":"Proximal tubular injury and rapid formation of atubular glomeruli in mice with unilateral ureteral obstruction: a new look at an old model.","volume":"301","author":"Forbes","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"R109-7-20230208","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1016\/j.ajpath.2014.03.007","article-title":"Tubular obstruction leads to progressive proximal tubular injury and atubular glomeruli in polycystic kidney disease.","volume":"184","author":"Galarreta","year":"2014","journal-title":"Am J Pathol"},{"key":"R110-7-20230208","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1038\/ki.2013.501","article-title":"Renal cyst growth is the main determinant for hypertension and concentrating deficit in Pkd1-deficient mice.","volume":"85","author":"Fonseca","year":"2014","journal-title":"Kidney Int"},{"key":"R111-7-20230208","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1681\/ASN.2007060688","article-title":"Vasopressin directly regulates cyst growth in polycystic kidney disease.","volume":"19","author":"Wang","year":"2008","journal-title":"J Am Soc Nephrol"}],"container-title":["Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001751-201509000-00007","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T19:26:22Z","timestamp":1786130782000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001751-201509000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":110,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015]]}},"URL":"https:\/\/doi.org\/10.1681\/asn.2014121192","relation":{},"ISSN":["1046-6673"],"issn-type":[{"value":"1046-6673","type":"print"}],"subject":[],"published":{"date-parts":[[2015,9]]}}}